STERIS plc (NYSE:STE) — Market Cap & Net Worth
Market Cap & Net Worth: STERIS plc (STE)
STERIS plc (NYSE:STE) has a market capitalization of $20.36 Billion ($20.36 Billion) as of September 24, 2026. Listed on the NYSE stock exchange, this USA-based company holds position #1268 globally and #526 in its home market, demonstrating a -2.28% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying STERIS plc's stock price $208.79 by its total outstanding shares 98075025 (98.08 Million). Also see STE total asset value for a full breakdown of the balance sheet.
STERIS plc Market Cap History: 2015 to 2026
STERIS plc's market capitalization history from 2015 to 2026. Data shows growth from $6.70 Billion to $20.48 Billion (11.94% CAGR). Also see STE cash generation efficiency for how efficiently the company converts equity into cash flow.
Index Memberships
STERIS plc is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
S&P 500 Index
GSPC
|
$63.30 Trillion | 0.05% | #360 of 503 |
Weight: STERIS plc's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
STERIS plc Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how STERIS plc's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check STERIS plc share price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
4.55x
STERIS plc's market cap is 4.55 times its annual revenue
Latest Price to Earnings (P/E) Ratio
40.45x
STERIS plc's market cap is 40.45 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $6.08 Billion | $2.24 Billion | $110.76 Million | 2.72x | 54.93x |
| 2017 | $8.02 Billion | $2.61 Billion | $109.97 Million | 3.07x | 72.89x |
| 2018 | $9.91 Billion | $2.62 Billion | $290.92 Million | 3.78x | 34.07x |
| 2019 | $14.28 Billion | $2.78 Billion | $304.05 Million | 5.13x | 46.97x |
| 2020 | $17.92 Billion | $3.03 Billion | $407.66 Million | 5.91x | 43.96x |
| 2021 | $23.20 Billion | $3.11 Billion | $397.40 Million | 7.47x | 58.39x |
| 2022 | $17.77 Billion | $4.22 Billion | $243.89 Million | 4.21x | 72.85x |
| 2023 | $21.36 Billion | $4.54 Billion | $107.03 Million | 4.71x | 199.54x |
| 2024 | $20.16 Billion | $5.14 Billion | $378.24 Million | 3.92x | 53.30x |
| 2025 | $24.86 Billion | $5.46 Billion | $614.64 Million | 4.55x | 40.45x |
Competitor Companies of STE by Market Capitalization
Companies near STERIS plc in the global market cap rankings as of September 24, 2026. Review STE goodwill-adjusted equity ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to STERIS plc by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #122 globally with a market cap of $180.30 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #228 globally with a market cap of $109.30 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #237 globally with a market cap of $105.52 Billion USD.
- Medtronic plc (SA:MDTC34): Ranked #240 globally with a market cap of $104.84 Billion USD ( R$534.32 Billion BRL).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #122 | Abbott Laboratories | NYSE:ABT | $180.30 Billion | $103.69 |
| #228 | Medtronic PLC | NYSE:MDT | $109.30 Billion | $90.77 |
| #237 | Stryker Corporation | NYSE:SYK | $105.52 Billion | $275.09 |
| #240 | Medtronic plc | SA:MDTC34 | $104.84 Billion | R$208.39 |
STERIS plc Historical Marketcap From 2015 to 2026
Between 2015 and today, STERIS plc's market cap moved from $6.70 Billion to $ 20.48 Billion, with a yearly change of 11.94%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | $20.48 Billion | -17.64% |
| 2025 | $24.86 Billion | +23.33% |
| 2024 | $20.16 Billion | -5.60% |
| 2023 | $21.36 Billion | +20.20% |
| 2022 | $17.77 Billion | -23.43% |
| 2021 | $23.20 Billion | +29.47% |
| 2020 | $17.92 Billion | +25.50% |
| 2019 | $14.28 Billion | +44.09% |
| 2018 | $9.91 Billion | +23.66% |
| 2017 | $8.02 Billion | +31.73% |
| 2016 | $6.08 Billion | -9.14% |
| 2015 | $6.70 Billion | -- |
End of Day Market Cap According to Different Sources
On Sep 23rd, 2026 the market cap of STERIS plc was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $20.36 Billion USD |
| MoneyControl | $20.36 Billion USD |
| MarketWatch | $20.36 Billion USD |
| marketcap.company | $20.36 Billion USD |
| Reuters | $20.36 Billion USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About STERIS plc
STERIS plc provides infection prevention products and services worldwide. It operates in three segments: Healthcare, Applied Sterilization Technologies (AST), and Life Sciences. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital … Read more